2025-12-19 - Analysis Report
Okay, here's a comprehensive analysis of PPG Industries Inc. (PPG), based on the data you provided.

**0) PPG Industries Inc Overview:** PPG Industries Inc. is a global supplier of paints, coatings, and specialty materials.

**1) Return Rate Comparison:**

*   **PPG Cumulative Return:** -38.74%
*   **VOO (S&P 500) Cumulative Return:** 99.09%
*   **Divergence:** -138.1 (Current), -146.0 (Min), 4.9 (Max), 5.2 (Relative Divergence)

*Analysis:* PPG has significantly underperformed the S&P 500 (VOO) over the period examined. The divergence of -138.1 indicates a substantial difference in cumulative returns. The Relative Divergence of 5.2 suggests the current divergence is near the low end of its historical range relative to its best and worst divergence compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 15.0% | 5.5% | -14.0% | 0.1 | 26.4 |
| 2016-2018  | 8.0% | 69.1% | -7.0% | 0.1 | 23.1 |
| 2017-2019  | 19.0% | 71.1% | -3.0% | -0.3 | 30.1 |
| 2018-2020  | -17.0% | 78.6% | -41.0% | -0.4 | 32.5 |
| 2019-2021  | 12.0% | 78.6% | -35.0% | -0.7 | 38.9 |
| 2020-2022  | -18.0% | 81.0% | -17.0% | -0.9 | 28.4 |
| 2021-2023  | -2.0% | 81.0% | -3.0% | -0.9 | 33.8 |
| 2022-2024  | -31.0% | 81.0% | -52.0% | -1.2 | 27.0 |
| 2023-2025  | -23.0% | 80.6% | -86.0% | -1.0 | 23.2 |

*Analysis:*
*   **CAGR:** The Compound Annual Growth Rate shows varying performance, with some periods showing positive growth but recent years showing significant declines.
*   **MDD:** The Maximum Drawdown is high across all periods, indicating significant volatility and potential for losses. This is a major red flag.
*   **Alpha:** The consistently negative Alpha values suggest that PPG has underperformed its benchmark (likely the S&P 500) on a risk-adjusted basis.  This means it hasn't delivered returns commensurate with the risk taken.
*   **Beta:** Beta values are mostly near or below zero (negative trend recently), suggesting a weaker correlation with the overall market, which might mean it's less sensitive to market movements, but it is also more likely to underperform when the market is increasing.
*   **Cap:** Fluctuation in market capitalization (Cap) shows some volatility in company valuation.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 102.91
*   **Previous Close:** 103.72
*   **Change:** -0.78
*   **5-day SMA:** 103.518
*   **20-day SMA:** 100.7848
*   **60-day SMA:** 100.264

*Analysis:* The stock price has decreased slightly in the most recent session. The 5-day SMA is above the 20-day and 60-day SMAs, indicating a possible short-term upward trend.

**3) Indicators Analysis:**

*   **MRI:** 0.7 (Medium Investment)
*   **RSI:** 65.80 (Approaching Overbought)
*   **PPO:** 0.389
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (10 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Divergence Change:** 2.5 (+) (Short-term Increase)
*   **Expected Return:** -1341.6% (Very Negative)

*Analysis:*

*   The MRI suggests a medium level of investment risk.
*   The RSI is approaching overbought territory, suggesting the stock may be due for a pullback.
*   The PPO (Percentage Price Oscillator) is positive, indicating a potential upward trend.
*   The Hybrid Signal recommends buying, despite the extremely negative expected return. This likely stems from a model that prioritizes risk management and long-term accumulation.
*   The recent increase in relative divergence (2.5) suggests a recent short-term upward movement.
*   The extremely negative Expected Return is alarming. This suggests the model predicts significant underperformance relative to the S&P 500 over the long term.

**4) Recent News & Significant Events:**

*   **Positive Analyst Ratings:** Several articles highlight positive analyst outlooks, with price targets ranging from $119 to $130. Citigroup analyst expects the stock price to rise.
*   **REDCert² Certification:** PPG secured REDCert² for Amsterdam, Søborg coatings plants in EU.
*   **Stock Prediction (TIKR.com):** Reports on where analysts see the stock going by 2027.
*   **(PPG) Movement as an Input in Quant Signal Sets:** News article which implies the usage of price movement in quantative data analysis.

*Analysis:* Recent news is predominantly positive, with analyst upgrades and positive price target adjustments. Securing certifications reflects a commitment to sustainability.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean = 2.17)
*   **Target Price:** $119.00 (Average), $130.00 (High), $109.00 (Low)
*   **Recent Rating Changes:** No significant rating changes are specified.

*Analysis:* The analyst consensus is currently a "Buy," with an average target price significantly above the current price, suggesting potential upside.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue    |
|------------|------|-------------|
| 2025-10-29 | 2.01 | 4.08 B$    |
| 2025-07-30 | 1.98 | 4.20 B$    |
| 2025-04-30 | 1.63 | 3.68 B$    |
| 2024-10-17 | 2.01 | 4.03 B$    |
| 2025-10-29 | 2.01 | 4.03 B$    |

*Analysis:* Earnings per share (EPS) has fluctuated, with the most recent EPS mirroring what it was a year ago. Revenue has shown some variability, with the most recent quarter showing a slight decrease compared to the previous quarter.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $4.08B  | 40.57%        |
| 2025-06-30   | $4.20B  | 42.03%        |
| 2025-03-31   | $3.68B  | 41.86%        |
| 2024-12-31   | $2.17B  | 34.87%        |
| 2024-09-30   | $4.03B  | 40.95%        |

*Analysis:* Revenue has been generally strong except for the last quarter of 2024. Profit margins appear consistently high, indicating strong cost control and pricing power.

**Capital and Profitability:**

| Quarter      | Equity  | ROE    |
|--------------|---------|--------|
| 2025-09-30   | $7.80B  | 5.81%  |
| 2025-06-30   | $7.58B  | 5.94%  |
| 2025-03-31   | $6.93B  | 5.38%  |
| 2024-12-31   | $6.79B  | -4.13% |
| 2024-09-30   | $7.79B  | 6.01%  |

*Analysis:* Equity has fluctuated slightly. Return on Equity (ROE) has been positive except for one period, suggesting reasonable profitability relative to shareholder equity, but has declined slightly recently.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** PPG has significantly underperformed the S&P 500.
*   **Volatility:** High Maximum Drawdown values indicate high price volatility and risk.
*   **Negative Alpha:** Consistently negative Alpha values indicate poor risk-adjusted performance.
*   **Mixed Indicators:** While the MRI suggests moderate risk, the RSI is approaching overbought. The expected return is extremely negative.
*   **Positive News & Analyst Outlook:** Recent news and analyst ratings are generally positive, suggesting potential upside.
*   **Strong Financials:** Revenue and profitability metrics appear strong.
*   **Hybrid Model Recommendation:** Hybrid signal recommends buying.

**Conclusion:**

The data paints a mixed picture. PPG has underperformed the market significantly and exhibits high volatility and negative alpha. The extremely negative expected return is concerning. However, recent positive news and analyst ratings, along with consistently strong revenue and profit margins, offer some hope for a potential turnaround. The Hybrid Model suggesting a buy rating provides an additional perspective that emphasizes risk management. Investors should weigh these factors carefully, recognizing the inherent risks despite the positive signals. A good investor would consider conducting further research into the reasons for PPG's underperformance and the sustainability of its profitability.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.